Want to join the conversation?
Surgical devices manufacturer $ISRG reported higher 4Q15 earnings of $190MM or $4.99 per share, an increase 29% compared to a year ago period. The YoverY increase was helped by revenue growth across all of its segments and margin expansion. Revenue rose by 12% to $677MM for the quarter compared to $605MM a year ago.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.